Sponsor Dossier
Gilead Sciences
Sponsor Dossier for Gilead Sciences. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AMBISOME
- Brand: BIKTARVY
- Brand: DESCOVY
- Brand: EPCLUSA
- Brand: EVIPLERA
- Brand: GENVOYA
- Brand: HARVONI
- Brand: HEPCLUDEX
About
Gilead Sciences is an Australian Private Company with ABN 71 072 611 708, registered in Victoria. The entity is currently active.
Portfolio
Gilead Sciences has 21 brands on the ARTG, of which 20 are indexable and 20 carry a Product Information document. 8 brands are PBS-listed, 15 have a PBAC outcome on record, and 16 have an AusPAR on record. Notable brands include AMBISOME, BIKTARVY, DESCOVY, EPCLUSA, EVIPLERA, GENVOYA, HARVONI, HEPCLUDEX, LIVDELZI, Lyophilized, ODEFSEY, STRIBILD.
Therapeutic focus
— Infectious Disease: 16 brands — Hepatology: 3 brands — Oncology: 2 brands
PBS footprint
8 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2025-12-01, across 15 brands with a PBAC outcome on record. The latest AusPAR is 2026-06-30, across 16 brands with an AusPAR on record.